- Report
- January 2024
- 26 Pages
Global
€15166EUR$17,150USD£13,141GBP
- Report
- January 2024
- 120 Pages
Global
From €7030EUR$7,950USD£6,091GBP
- Report
- December 2023
- 182 Pages
Global
€4417EUR$4,995USD£3,827GBP
- Report
- November 2023
- 381 Pages
Global
€4417EUR$4,995USD£3,827GBP
- Report
- October 2023
- 240 Pages
Global
€4240EUR$4,795USD£3,674GBP
- Report
- August 2023
- 220 Pages
Global
€4063EUR$4,595USD£3,521GBP
- Report
- July 2023
- 120 Pages
Global
From €3979EUR$4,500USD£3,448GBP
- Report
- July 2023
- 180 Pages
Global
From €3979EUR$4,500USD£3,448GBP
- Report
- July 2023
- 214 Pages
Global
From €3979EUR$4,500USD£3,448GBP
- Report
- April 2023
- 46 Pages
Global
From €4417EUR$4,995USD£3,827GBP
- Report
- November 2022
- 31 Pages
Global
€10833EUR$12,250USD£9,386GBP
- Report
- August 2022
- 27 Pages
Global
From €1194EUR$1,350USD£1,034GBP
- Report
- August 2022
- 37 Pages
United States
From €902EUR$1,020USD£782GBP
- Report
- January 2022
- 148 Pages
Global
From €3758EUR$4,250USD£3,256GBP
From €3758EUR$4,250USD£3,256GBP
- Report
- September 2021
- 19 Pages
Thailand
From €825EUR$999USD£740GBP
- Report
- March 2019
- 110 Pages
Global
From €2874EUR$3,250USD£2,490GBP
- Drug Pipelines
- February 2019
- 300 Pages
Global
From €19455EUR$22,000USD£16,857GBP
- Report
- June 2018
- 16 Pages
Global
From €8843EUR$10,000USD£7,662GBP
- Report
- June 2018
- 15 Pages
Global
From €8843EUR$10,000USD£7,662GBP

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups.
The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products.
Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more